Effects of divalproex versus lithium on length of hospital stay among patients with bipolar disorder

Psychiatric Services

Volumn 51, Issue 9, 2000, Pages 1184-1186

  Dalkilic, A ^a   Diaz, E ^a   Baker, C B ^a   Pearsall, H R ^a   Woods, S W ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; LITHIUM; NEUROLEPTIC AGENT; VALPROATE SEMISODIUM;

ADULT; ARTICLE; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; HOSPITALIZATION; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; PSYCHIATRIC TREATMENT;

ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; CONNECTICUT; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; LENGTH OF STAY; LITHIUM; MALE; PROSPECTIVE STUDIES; VALPROIC ACID;

EID: 0033852643     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.51.9.1184     Document Type: Article

References (7)

1. A pharmacoeconomic model of divalproex vs lithium in the acute and prophylactic treatment of bipolar I disorder
2. Cost-effectiveness of divalproex versus lithium (ltr)
3. The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay
4. Association between mood-stabilizing medication and mental health resource use in the management of acute mania
5. Dosing strategies and time course of response to antimanic drugs
6. Valproate oral loading in the treatment of acute mania
7. Rapid titration of mood stabilizers predicts remission from mixed or pure mania in bipolar patients